Parnassus Value Equity Fund Q3 2026 Portfolio Review

Parnassus Value Equity Fund (Investor Shares) returned -1.38% (net of fees) for the quarter, underperforming the Russell 1000 Value Index's 2.61%. Top contributors include Thermo Fisher, CME Group, NICE, Willis Towers Watson and Verizon. Bottom contributors include Cummins, Applied Materials, Brookfield Renewable, Home Depot and AstraZeneca.

Seeking Alpha • Oct 27, 2026

Baron Health Care Fund Q3 2026 Top Contributors And Detractors

TMO's organic growth of 5% exceeded consensus by 200 basis points, and management raised full-year organic growth guidance/. MTD's local-currency sales grew 6%, exceeding prior guidance of 3%. TEVA management raised guidance for all three brands.

Seeking Alpha • Oct 26, 2026

Nasdaq Gains 1%; Thermo Fisher Scientific Posts Upbeat Earnings

Thermo Fisher Scientific Inc. (NYSE:TMO) posted upbeat third-quarter results and raised its FY2026 forecast.

Benzinga • Oct 21, 2026

Thermo Fisher Scientific: 3 Key Takeaways for Long-Term Investors

Thermo Fisher raised its 2026 organic revenue growth outlook to 4%. Third-quarter revenue reached $12.14 billion with 6% organic growth.

The Motley Fool • Oct 21, 2026

Thermo Fisher posts higher third-quarter revenue and earnings as margins improve

Thermo Fisher Scientific Inc (NYSE:TMO, XETRA:TN8) increased third-quarter revenue by 9% to $12.14 billion, while adjusted earnings per share rose 15% to $6.68. Revenue for the three months ended September 2026 increased from $11.12 billion a year earlier, with organic revenue growth, which excludes the effects of acquisitions, disposals and currency movements, reaching 6%.

Proactive Investors • Oct 21, 2026

Thermo Fisher Scientific Q3 Earnings Call Highlights

Thermo Fisher Scientific NYSE: TMO reported third-quarter revenue growth of 9% to $12.14 billion, supported by 6% organic growth, acquisitions and foreign-exchange effects. Adjusted earnings per share rose 15% to $6.68, while adjusted operating income increased 15% to $2.97 billion.

MarketBeat • Oct 21, 2026

Thermo Fisher Scientific Reports Third Quarter 2026 Results

WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today reported its financial results for the third quarter ended September 26, 2026. Third Quarter Highlights Third quarter revenue grew 9% to $12.14 billion Third quarter GAAP diluted earnings per share (EPS) grew 9% to $4.64 Third quarter adjusted EPS grew 15% to $6.68 “We are very pleased to deliver another excellent quarter, with outstanding financial performance on both the top.

Business Wire • Oct 21, 2026

Thermo Fisher Scientific Inc. (TMO) Q3 2026 Earnings Call Transcript

Thermo Fisher Scientific Inc. (TMO) Q3 2026 Earnings Call Transcript

Seeking Alpha • Oct 21, 2026

Thermo Fisher Scientific (TMO) Tops Q3 Earnings and Revenue Estimates

Thermo Fisher Scientific (TMO) came out with quarterly earnings of $6.68 per share, beating the Zacks Consensus Estimate of $6.4 per share. This compares to earnings of $5.79 per share a year ago.

Zacks Investment Research • Oct 21, 2026

Compared to Estimates, Thermo Fisher (TMO) Q3 Earnings: A Look at Key Metrics

Although the revenue and EPS for Thermo Fisher (TMO) give a sense of how its business performed in the quarter ended September 2026, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

Zacks Investment Research • Oct 21, 2026